Advertisement
U.S. markets open in 2 hours 15 minutes

Laboratorios Farmaceuticos Rovi, S.A. (ROVI.MC)

MCE - MCE Delayed Price. Currency in EUR
80.45-0.20 (-0.25%)
As of 11:58AM CET. Market open.
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close80.65
Open80.70
Bid80.40 x 0
Ask80.50 x 0
Day's Range79.95 - 80.70
52 Week Range37.96 - 81.50
Volume6,930
Avg. Volume80,184
Market Cap4.13B
Beta (5Y Monthly)0.47
PE Ratio (TTM)25.14
EPS (TTM)3.20
Earnings DateMay 08, 2024 - May 13, 2024
Forward Dividend & Yield1.29 (1.60%)
Ex-Dividend DateJul 03, 2023
1y Target Est68.09
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for ROVI.MC

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Reuters

      UPDATE 2-Moderna to cut mRNA drug substance production at Lonza facility

      Moderna said on Tuesday it will cut production of mRNA drug substance for its COVID-19 vaccine at Lonza's facility in Switzerland this quarter as part of a plan to align manufacturing of the shots with lower post-pandemic demand. The U.S. company had said last week it was in talks with its partners that fill vials and syringes globally to downsize vaccine production. Such a move will help Moderna adjust to the sharp fall in demand for COVID vaccines as payers cut back orders for the shots, partly following the end of the public health emergency for the disease.